fashion -WSS

fashion

author：knowledge 2025-09-28 00:51:35 - browse：6975

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： CDC director unscathed in first congressional testimony

hotspot

leisure time

WSS

Can medical device makers keep up in the race to treat obesity?

Will the market for weight loss drugs really reach $100 billion?

UnitedHealth’s Optum accused of antitrust violations in California

FDA approves first new drug developed for postpartum depression

Takeda, Janssen join wearable maker to measure scratching

Mom launches Girl Scout troop for LGBTQ youth in Texas

hotspot

fashion

knowledge

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Xenotransplantation trials will require adjusting expectations, experts say

Medical leaders decry Supreme Court decision on affirmative action

U.K. Biobank has 500,000 peoples' genome sequences available

Cancer drug shortages should be causing more outrage

Cigna, Humana reportedly in talks to merge

Medicare details structure of new drug price negotiation program

Can medical device makers keep up in the race to treat obesity?

Cancer drug shortages should be causing more outrage

FDA investigates CAR

leisure time

How to pay for weight loss drugs and save Medicare

Altering the blood type of lungs raises potential for universal organs for transplants

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

What don’t we know about an Alzheimer’s drug side effect?

Altering the blood type of lungs raises potential for universal organs for transplants

The EPA's new lead rule: How one expert crunched the numbers

hotspot

leisure time

leisure time

entertainment